Details for New Drug Application (NDA): 212060
✉ Email this page to a colleague
NDA 212060 describes HEPARIN SODIUM PRESERVATIVE FREE, which is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Hospira, Nanjing King-friend, Pfizer, Pharma Serve Ny, Sagent Pharms, and Shenzhen Techdow, and is included in nine NDAs. It is available from twelve suppliers. Additional details are available on the HEPARIN SODIUM PRESERVATIVE FREE profile page.
The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 212060
| Tradename: | HEPARIN SODIUM PRESERVATIVE FREE |
| Applicant: | Nanjing King-friend |
| Ingredient: | heparin sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 212060
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HEPARIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 212060 | ANDA | Meitheal Pharmaceuticals Inc. | 71288-405 | 71288-405-81 | 24 BLISTER PACK in 1 CARTON (71288-405-81) / 1 SYRINGE, GLASS in 1 BLISTER PACK (71288-405-80) / .5 mL in 1 SYRINGE, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10,000 UNITS/ML | ||||
| Approval Date: | Apr 2, 2020 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
